Evidence map›Paper›PMID 39769197›Full record

ArticleInternational journal of molecular sciences2024

Investigation of

Anna Kałuża, Katarzyna Trzęsicka, Damian Drzyzga, Mirosława Ferens-Sieczkowska

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anna KałużaDepartment of Biochemistry and Immunochemistry, Division of Chemistry and Immunochemistry, Wroclaw Medical University, M. Skłodowskiej-Curie 48/50, 50-369 Wroclaw, Poland.ORCID 0000-0003-0161-3012
Katarzyna TrzęsickaINVICTA, Research and Development Center, Polna 64, 81-740 Sopot, Poland.ORCID 0009-0004-2728-0273
Damian DrzyzgaINVICTA, Research and Development Center, Polna 64, 81-740 Sopot, Poland.ORCID 0000-0002-6466-2412
Mirosława Ferens-SieczkowskaDepartment of Biochemistry and Immunochemistry, Division of Chemistry and Immunochemistry, Wroclaw Medical University, M. Skłodowskiej-Curie 48/50, 50-369 Wroclaw, Poland.ORCID 0000-0001-8578-7487

Funding

National Science Centre, Poland 2021/05/X/NZ5/00980Wroclaw Medical University SUBK.A411.23.066
6 · The paper itself

Abstract

Prolactin induced-protein (PIP) has been found to be rich in immunomodulatory epitopes, including

Indexed as

Amino SugarsGalectin 3SemenAdultBlood ProteinsGalectinsGlycodelinGlycoproteinsHumansLigandsMaleMembrane Transport ProteinsPlant LectinsPolysaccharidesProtein BindingAmino SugarsBlood ProteinsGalectin 3GalectinsGlycodelinGlycoproteinsLGALS3 protein, humanLigandsMembrane Transport ProteinsN-acetyllactosaminePAEP protein, humanPIP protein, humanPlant LectinsPolysaccharidescarbohydrate protein interactiongalectin-3immunomodulatory epitopesN-acetyllactosamineN,N-diacetyllactosamineprolactin-induced proteinseminal plasma

Identifiers

PMID39769197
PMCPMC11678142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.